1st Pharmacovigilance Annual Meeting
With the join of previous China Food and Drug Administration（pre-CFDA） officially with the International Human Drug Registration Technical Requirements Coordination Meeting (ICH) in June 2017, the MAH directly reporting system was officially implemented on January 1, 2019 and in other general environment, the function of the pharmaceutical company's pharmacovigilance went to the front desk from behind the scenes. For this purpose, the first CMAC Pharmacovigilance Annual Meeting will be held. The pharmaceutical company's pharmacovigilance practitioners and management team will be invited to participate. The estimated scale will be more than 350, and the number of pharmacovigilance principal will exceed 200.
The meeting will focus on the conference theme: “Pharmacovigilance: reviewing the situation, starting from the momentum”, starting from the aspects of the construction of the pharmacovigilance system and the operation of the pharmacovigilance team and personnel development, etc. The content of the meeting is rich and colorful, leading to new thinking. Sincerely invite pharmacovigilance, medical affairs, marketing, sales, and government affairs colleagues to participate actively.